Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer

AIM: The aim of this study is to characterize the effect of chemotherapy drug doxorubicin with neoadjuvant drug docetaxel for different molecular subtypes. METHODS: A total of 83 patients with late-stage breast cancer were chosen to undergo treatment and compared to these patients to the combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ling-Cheng, Wang, Ling-Sheng, Li, Ai-Xia, Shi, Zhen-Zong, Li, Ya-Qiong, Huang, Wei, Chen, Shi-Man, Han, Fei, Zhu, De-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281880/
https://www.ncbi.nlm.nih.gov/pubmed/32508292
http://dx.doi.org/10.1177/1533033820928435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281880/
https://www.ncbi.nlm.nih.gov/pubmed/32508292
http://dx.doi.org/10.1177/1533033820928435

Ejemplares similares